Article in Journal of clinical microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors.
Carlos SernaAntimicrobial Resistance Unit (ARU), Department of Animal Health, VISAVET Health Surveillance Centre, Faculty of Veterinary Medicine, Complutense University of Madrid, Madrid, Spain.ORCID 0000-0002-6008-6024
Mario Pulido-VadilloAntimicrobial Resistance Unit (ARU), Department of Animal Health, VISAVET Health Surveillance Centre, Faculty of Veterinary Medicine, Complutense University of Madrid, Madrid, Spain.ORCID 0000-0002-3082-2692
Bosco R MatamorosAntimicrobial Resistance Unit (ARU), Department of Animal Health, VISAVET Health Surveillance Centre, Faculty of Veterinary Medicine, Complutense University of Madrid, Madrid, Spain.
Javier F FavieresAntimicrobial Resistance Unit (ARU), Department of Animal Health, VISAVET Health Surveillance Centre, Faculty of Veterinary Medicine, Complutense University of Madrid, Madrid, Spain.ORCID 0000-0002-8178-4665
Natalia MonteroAntimicrobial Resistance Unit (ARU), Department of Animal Health, VISAVET Health Surveillance Centre, Faculty of Veterinary Medicine, Complutense University of Madrid, Madrid, Spain.
Claudia García BerdúnAntimicrobial Resistance Unit (ARU), Department of Animal Health, VISAVET Health Surveillance Centre, Faculty of Veterinary Medicine, Complutense University of Madrid, Madrid, Spain.
Marta E GarcíaDepartment of Animal Health, Faculty of Veterinary Medicine, Complutense University of Madrid, Madrid, Spain.
Jose L BlancoDepartment of Animal Health, Faculty of Veterinary Medicine, Complutense University of Madrid, Madrid, Spain.ORCID 0000-0001-8142-0450
Jose F Delgado-BlasAntimicrobial Resistance Unit (ARU), Department of Animal Health, VISAVET Health Surveillance Centre, Faculty of Veterinary Medicine, Complutense University of Madrid, Madrid, Spain.ORCID 0000-0001-6447-7113
Bruno Gonzalez-ZornAntimicrobial Resistance Unit (ARU), Department of Animal Health, VISAVET Health Surveillance Centre, Faculty of Veterinary Medicine, Complutense University of Madrid, Madrid, Spain.ORCID 0000-0002-6958-4716
Funding
Ministerio de Ciencia e Innovación PLEC2023-010275
6 · The paper itself
Abstract
Aminoglycoside resistance mediated by 16S rRNA methyltransferases poses a growing threat in both human and veterinary medicine. Here, we conducted a retrospective genomic study of Enterobacterales isolates (
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Persistent multispecies dissemination of · full record | OpenQuestion